Case Control Study
Copyright ©The Author(s) 2018.
World J Clin Cases. Nov 6, 2018; 6(13): 600-610
Published online Nov 6, 2018. doi: 10.12998/wjcc.v6.i13.600
Table 1 Demographic and clinical characteristics of the participants in the study groups
HC
CHB
LC
HCC
P-value
Characteristic(n = 78)(n = 78)(n = 85)(n = 77)
Gender (M/F)48/3053/2554/3162/150.05
Age (yr)44 (25-67)46 (30-61)49 (27-65)49 (22-57)0.137
ALT (U/L)14.95 (4.4-564)122.9 (7-1906)64 (8-855)41 (15-450.2)< 0.01
AST (U/L)21.55 (11.0-38.5)75.5 (14-1499)56 (16-845)56 (19-634)< 0.01
ALB (g/L)48.22 ± 2.5138.01 ± 5.8232.10 ± 6.8734.56 ± 6.56< 0.01
HGB (g/L)147.79 ± 13.80145.41 ± 17.74126.33 ± 22.70133.58 ± 22.5< 0.01
PLT (× 109/L)217 (117-328)152.5 (55-298)79 (28-303)124 (17-515)< 0.01
APRI0.24 (0.1-0.5)1.25 (0.16-68.14)2.05 (0.24-42.25)1.49 (0.24-9.43)< 0.01
HBV-DNA (Log10)0 (0-0)6.64 (1.3-8.91)4.96 (1.7-8.35)4.61 (1.7-7.88)< 0.01
Table 2 Factors associated with serum hepcidin concentration in multiple linear regression models
Correlation analysis
Linear regression analysis
CharacteristicrhoP-valueEffect sizeP -value
Age (yr)0.3< 0.010.2130.001
Gender0.010.986--
ALT (U/L)-0.0950.141--
AST (U/L)-0.0130.842--
GGT (U/L)0.0110.871--
AKP (U/L)0.1230.058--
ALB (g/L)-0.0550.394--
TBIL (μmol/L)0.1080.096--
TBA (μmol/L)0.1960.002
HBV-DNA (Log10)-0.374< 0.01-0.282< 0.001
APRI0.1140.077--
RBC (× 1012/L)-0.1530.018
WBC (× 109/L)-0.1190.065--
PLT (× 109/L)-0.1950.002
HGB (g/L)-0.1580.014
MCV (fL)0.010.879--
HCT (L/L)-0.1620.012
INR0.1880.0030.198< 0.001
Serum iron (μmol/L)0.0270.672--
Total iron binding capacity (μmol/L)-0.0730.261--
Serum ferritin (μg/L)-0.130.836--
Transferrin saturation (%)0.0560.387--
transferrin (g/L)0.0020.98--